Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Jill E Slansky

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Slansky, Jill

One or more keywords matched the following items that are connected to Slansky, Jill

Item Type	Name
Academic Article	Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines.
Academic Article	Live attenuated Listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced by depletion of regulatory T cells.
Academic Article	Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity.
Academic Article	Elevated tumor-associated antigen expression suppresses variant peptide vaccine responses.
Academic Article	TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
Academic Article	Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes.
Academic Article	Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastases.
Academic Article	A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model.
Academic Article	Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens.
Academic Article	Improving T cell responses to modified peptides in tumor vaccines.
Academic Article	Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens.
Concept	Cancer Vaccines
Academic Article	Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor.
Academic Article	Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer.

Search Criteria

Cancer Vaccines